Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-16-007166)

Filing Details

Accession Number:: 0001493152-16-007166
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-02-04 17:14:51
Reporting Period:: 2015-09-02

Filing Date:: 2016-02-04
Accepted Time:: 2016-02-04 17:14:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1362703	Oncbiomune Pharmaceuticals Inc	OBMP	Services-Advertising (7310)	202590810

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1653954	Jr Lange Robert Elliot	C/O Oncbiomune Pharmaceuticals, Inc. 11441 Industriplex Blvd., Suite 190 Baton Rouge LA 70809		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-09-02	17,951,079	$0.00	17,951,079	No	4	A	Direct
Common Stock	Disposition	2015-09-02	1,025,000	$0.00	16,926,079	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

Received in exchange for all of the reporting person's shares of OncBioMune, Inc. ("ONC") common stock in connection with the exchange pursuant to that certain exchange agreement dated as of June 22, 2015, as amended, among the registrant, ONC and the ONC shareholders.